Mucoadhesive Nanoemulsions for Nose-to-Brain Delivery of Dimethyl Fumarate: Development, Characterization and Proof-of-Concept In Vivo Evaluation
Authors:
- Eleonora Sofia CamaECEleonora Sofia Cama
- Giada BottiGiada Botti
- Sara PerteghellaSPSara Perteghella
- Laura CatenacciLaura Catenacci
- Fahad Khan TareenFTFahad Khan Tareen
- Sarah BeggiatoSBSarah Beggiato
- Maria Cristina BonferoniMaria Cristina Bonferoni
- Luca FerraroLuca Ferraro
- Milena SorrentiMilena Sorrenti
- Alessandro DalpiazADAlessandro Dalpiaz
Open Access
- 16 September 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (9) , 1168
Abstract
Background: Dimethyl fumarate (DMF) is an approved therapeutic agent for the treatment of multiple sclerosis, known for its anti-inflammatory and neuroprotective properties. However, its oral administration is often accompanied by gastrointestinal side effects, limiting its therapeutic potential. In the present study, a novel nanoemulsion (NE) formulation was developed and characterized with the aim of enhancing DMF exposure in the cerebrospinal fluid (CSF) following intranasal administration. Methods: The formulation was prepared via a self-emulsification method using geraniol (GER) as the oil phase, selected for its antioxidant properties, and chitosan oleate as a mucoadhesive stabilizer and absorption promoter. Physicochemical characterization, in vitro release, RPMI 2650 cell cytotoxicity, and permeability were evaluated. Finally, an optimized NE (1.08 ± 0.02 mg/mL DMF and 0.28 ± 0.01 mg/mL GER) was administered intranasally to adult male Sprague–Dawley rats to assess DMF and GER exposure in the CSF. Results: The NEs exhibited optimal physicochemical properties: a mean particle size of approximately 170 nm, a polydispersity index below 0.3, and a positive zeta potential (above 20 mV). Spectroscopic and thermal analyses confirmed GER and DMF compatibility and a reciprocal enhancement of stability. In vitro drug release studies revealed a fast release profile, with 81% of DMF released within 2 h, aligning with the rapid absorption expected from nasal administration. Cytotoxicity assays showed high biocompatibility (>86% viability up to 50 µM DMF), while permeability studies demonstrated significant absorption, with 60% of DMF and 90% of GER absorbed within 2–3 h, favored by smaller droplet size. In rats, intranasal delivery achieved maximum CSF concentrations of ~8 µg/mL for DMF and ~1.5 µg/mL for GER within 2 h. Conclusions: These findings provide pharmacokinetic proof-of-concept supporting further investigation of this intranasal formulation for CNS delivery of DMF.Keywords
Funding Information
- Università degli Studi di Ferrara (2024-FAR.L_DOCPAS_DA)
This publication has 92 references indexed in Scilit:
- Pharmacokinetics of Geraniol and Its Metabolites in Mice After Oral AdministrationFood Science & Nutrition, 2024
- Nose‐to‐brain delivery of nanotherapeutics: Transport mechanisms and applicationsWIREs Nanomedicine and Nanobiotechnology, 2024
- Role of B Cells in Multiple Sclerosis and Related DisordersAnnals of Neurology, 2020
- A Concise Review on Nano‐emulsion Formation by the Phase Inversion Composition (PIC) MethodJournal of Surfactants and Detergents, 2020
- Insight into the mechanism of action of dimethyl fumarate in multiple sclerosisJournal of Molecular Medicine, 2019
- Microencapsulation of capsanthin by self-emulsifying nanoemulsions and stability evaluationEuropean Food Research and Technology, 2014
- Detection of fumarate–glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolismArchives of Dermatological Research, 2013
- Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeabilityCytotechnology, 2012
- Determination of dimethyl fumarate in desiccant and antimould sachets by reversed‐phase liquid chromatographyBiomedical Chromatography, 2011
- Major differences in the dynamics of primary and secondary progressive multiple sclerosisAnnals of Neurology, 1991